2,043
Views
0
CrossRef citations to date
0
Altmetric
Coronavirus

Cost-based COVID-19 vaccination and willingness to pay: A post-pandemic review

ORCID Icon, , , , , & show all
Article: 2313860 | Received 31 Oct 2023, Accepted 31 Jan 2024, Published online: 15 Feb 2024

References

  • Pollard CA, Morran MP, Nestor-Kalinoski AL. The COVID-19 pandemic: a global health crisis. Physiol Genomics. 2020;52(11):549–9. doi:10.1152/physiolgenomics.00089.2020.
  • Shah A, Marks PW, Hahn SM. Unwavering regulatory safeguards for COVID-19 vaccines. JAMA. 2020;324(10):931–2. doi:10.1001/jama.2020.15725.
  • Koo JR, Cook AR, Park M, Sun Y, Sun H, Lim JT, Tam C, Dickens BL. Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study. Lancet Infect Dis. 2020;20(6):678–688. doi:10.1016/S1473-3099(20)30162-6.
  • Li Z, Guan X, Mao N, Luo H, Qin Y, He N, Zhu Z, Yu J, Li Y, Liu J, et al. Antibody seroprevalence in the epicenter Wuhan, Hubei, and six selected provinces after containment of the first epidemic wave of COVID-19 in China. Lancet Reg Health West Pac. 2021;8:8. doi:10.1016/j.lanwpc.2021.100094.
  • Druedahl LC, Minssen T, Price WN. Collaboration in times of crisis: a study on COVID-19 vaccine R&D partnerships. Vaccine. 2021;39(42):6291–6295. doi:10.1016/j.vaccine.2021.08.101.
  • World Health Organization. WHO issues its first emergency use validation for a COVID-19 vaccine and emphasizes need for equitable global access. [accessed 2023 Dec 20]. https://www.who.int/news/item/31-12-2020-who-issues-its-first-emergency-use-validation-for-a-covid-19-vaccine-and-emphasizes-need-for-equitable-global-access.
  • U.S. Food & Drugs. FDA approves first COVID-19 vaccine approval signifies key achievement for public health. [accessed 2023 Oct 1]. https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine.
  • Barry M, Temsah MH, Aljamaan F, Saddik B, Al-Eyadhy A, Alenezi S, Alamro N, Alhuzaimi AN, Alhaboob A, Alhasan K, et al. COVID-19 vaccine uptake among healthcare workers in the fourth country to authorize BNT162b2 during the first month of rollout. Vaccine. 2021;39(40):5762–5768. doi:10.1016/j.vaccine.2021.08.083.
  • Liu R, Zhang Y, Nicholas S, Leng A, Maitland E, Wang J. COVID-19 vaccination willingness among Chinese adults under the free vaccination policy. Vaccines (Basel). 2021;9(3):292. doi:10.3390/vaccines9030292.
  • Teperowski Monrad J, Quaade S, Powell-Jackson T. Supply, then demand?Health expenditure, political leanings, cost obstacles to care, and vaccine hesitancy predict state-level COVID-19 vaccination rates. Vaccine. 2022;40(45):6528–48. doi:10.1016/j.vaccine.2022.08.050.
  • Chen J, Lu H. New challenges to fighting COVID-19: virus variants, potential vaccines, and development of antivirals. Biosci Trends. 2021;15(2):126–128. doi:10.5582/bst.2021.01092.
  • Wouters OJ, Shadlen KC, Salcher-Konrad M, Pollard AJ, Larson HJ, Teerawattananon Y, Jit M. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. Lancet. 2021;397(10278):1023–1034. doi:10.1016/S0140-6736(21)00306-8.
  • Savulescu J. Good reasons to vaccinate: mandatory or payment for risk?. J Med Ethics. 2021;47(2):78–85. doi:10.1136/medethics-2020-106821.
  • World Health Organization. Director-General’s opening remarks at the World Health Assembly. 2021 May 24 [accessed 2023 Oct 29]. https://www.who.int/director-general/speeches/detail/director-general-s-opening-remarks-at-the-world-health-assembly—24-may-2021.
  • Torreele E, Amon JJ. Equitable COVID-19 vaccine access. Health Hum Rights. 2021; 23(1):273.
  • Tatar M, Shoorekchali JM, Faraji MR, Seyyedkolaee MA, Pagán JA, Wilson FA. COVID-19 vaccine inequality: a global perspective. J Glob Health. 2022;12. doi:10.7189/jogh.12.03072.
  • Mathur M, Mathur N, Khan N, Kumar D, Verma A. Predictors of ‘out-of-pocket expenditure’on routine immunization of under-five children: a regression analysis. Cureus. 2020;12(12). doi: 10.7759/cureus.11859.
  • Sallam M, Anwar S, Yufika A, Fahriani M, Husnah M, Kusuma HI, Raad R, Khiri NM, Abdalla RY, Adam RY, et al. Willingness-to-pay for COVID-19 vaccine in ten low-middle-income countries in Asia, Africa and South America: a cross-sectional study. Narra J. 2022;2(1):1–16. doi:10.52225/narra.v2i1.74.
  • Jackson CS, Gracia JN. Addressing health and health-care disparities: the role of a diverse workforce and the social determinants of health. Public Health Rep. 2014;129(2):57–61. doi:10.1177/00333549141291S211.
  • Solís Arce JS, Warren SS, Meriggi NF, Scacco A, McMurry N, Voors M, Syunyaev G, Malik AA, Aboutajdine S, Adeojo O, et al. COVID-19 vaccine acceptance and hesitancy in low-and middle-income countries. Nat Med. 2021;27(8):1385–94. doi:10.1038/s41591-021-01454-y.
  • Patwary MM, Alam MA, Bardhan M, Disha AS, Haque MZ, Billah SM, Kabir MP, Browning MHEM, Rahman MM, Parsa AD, et al. COVID-19 vaccine acceptance among low- and lower-middle-income countries: a rapid systematic review and meta-analysis. Vaccines (Basel). 2022;10(3):427. doi:10.3390/vaccines10030427.
  • Lupu D, Tiganasu R. COVID-19 vaccination and governance in the case of low, middle and high-income countries. BMC Public Health. 2023;23(1):1–23. doi:10.1186/s12889-023-15975-3.
  • Ali HA, Hartner AM, Echeverria-Londono S, Roth J, Li X, Abbas K, Portnoy A, Vynnycky E, Woodruff K, Ferguson NM, et al. Vaccine equity in low and middle income countries: a systematic review and meta-analysis. Int J Equity Health. 2022;21(1):1–30. doi:10.1186/s12939-022-01678-5.
  • Tagoe ET, Sheikh N, Morton A, Nonvignon J, Sarker AR, Williams L, Megiddo I. COVID-19 vaccination in lower-middle income countries: national stakeholder views on challenges, barriers, and potential solutions. Front Pub Health. 2021;9:709127. doi:10.3389/fpubh.2021.709127.
  • China’s Leader in Online Legal Research. Standing committee of the national people’s congress, standing committee of the national people’s congress. Vaccine administration law of the People’s Republic of China. 2019. [accessed 2023 Oct 25]. http://www.lawinfochina.com/display.aspx?id=30707&lib=law.
  • Zhang H, Patenaude B, Ma C, Fang H. Vaccine pricing strategies in China. BMJ Glob Health. 2023;8(7):e011405. doi:10.1136/bmjgh-2022-011405.
  • Fang H, Chen C, Fang Y, He X, Hou Z, Jiang M, Jiang Y, Li S, Liu Y, Sui B, et al. A guideline for economic evaluations of vaccines and immunization programs in China. Hum Vac Immunother. 2022;18(6):2132802. doi:10.1080/21645515.2022.2132802.
  • Zhang H, Lai X, Mak J, Sriudomporn S, Zhang H, Fang H, Patenaude B. Coverage and equity of childhood vaccines in China. JAMA Netw Open. 2022;5(12):e2246005. doi:10.1001/jamanetworkopen.2022.46005.
  • Tracie. COVID-19 healthcare delivery impacts. [accessed 2023 Oct 1]. https://files.asprtracie.hhs.gov/documents/covid-19-healthcare-delivery-impacts.pdf.
  • Filip R, Gheorghita Puscaselu R, Anchidin-Norocel L, Dimian M, Savage WK. Global challenges to public health care systems during the COVID-19 pandemic: a review of pandemic measures and problems. Journal Pers Med. 2022;12(8):1295. doi:10.3390/jpm12081295.
  • Arsenault C, Gage A, Kim MK, Kapoor NR, Akweongo P, Amponsah F, Aryal A, Asai D, Awoonor-Williams JK, Ayele W, et al. COVID-19 and resilience of healthcare systems in ten countries. Nat Med. 2022;28(6):1314–24. doi:10.1038/s41591-022-01750-1.
  • Okereke M, Ukor NA, Adebisi YA, Ogunkola IO, Favour Iyagbaye E, Adiela Owhor G, Lucero-Prisno DE 3rd DE. Impact of COVID-19 on access to healthcare in low- and middle-income countries: current evidence and future recommendations. Int J Health Plann Manage. 2021;36(1):13–17. doi:10.1002/hpm.3067.
  • Filip R, Gheorghita Puscaselu R, Anchidin-Norocel L, Dimian M, Savage WK. Global challenges to public health care systems during the COVID-19 pandemic: a review of pandemic measures and problems. J Pers Med. 2022;12(8):1295. doi:10.3390/jpm12081295.
  • Xu R, Wu L, Liu Y, Ye Y, Mu T, Xu C, Yuan H. Evaluation of the impact of the COVID-19 pandemic on health service utilization in China: a study using auto-regressive integrated moving average model. Front Public Health. 2023;11:1114085. doi:10.3389/fpubh.2023.1114085.
  • Di Bidino R, Cicchetti A. Impact of SARS-CoV-2 on provided healthcare. Evidence from the emergency phase in Italy. Front Public Health. 2020;8:583583. doi:10.3389/fpubh.2020.583583.
  • Eslami Jahromi M, Ayatollahi H. Utilization of telehealth to manage the Covid-19 pandemic in low- and middle-income countries: a scoping review. J Am Med Inform Assoc. 2023;30(4):738–751. doi:10.1093/jamia/ocac250.
  • Hermesh B, Rosenthal A, Davidovitch N, Clegg S. The cycle of distrust in health policy and behavior: lessons learned from the Negev Bedouin. PLoS One. 2020;15(8):e0237734. doi:10.1371/journal.pone.0237734.
  • Alang S, McAlpine DD, Hardeman R. Police brutality and mistrust in medical institutions. J Racial Ethn Health Disparities. 2020;7(4):760–8. doi:10.1007/s40615-020-00706-w.
  • Shen MJ. An equity-based strategy for COVID-19 vaccine distribution [accessed 2023 Oct 2]. https://blog.petrieflom.law.harvard.edu/2020/12/18/an-equity-based-strategy-for-covid-19-vaccine-distribution/.
  • Broach J, Brown O, McEachern C, Forget J, Lancette P, Soucie N, Inzerillo J, Klugman R, Tosi S, Haddad A, et al. The mobile vaccine equity enhancement program–a model program for enhancing equity in vaccine availability based at a large health care system. Front Pub Health. 2023;11:1271162. doi:10.3389/fpubh.2023.1271162.
  • Liau A, Stupiansky NW, Rosenthal SL, Zimet GD. Health beliefs and vaccine costs regarding human papillomavirus (HPV) vaccination among a US national sample of adult women. Prev Med. 2012;54(3–4):277–9. doi:10.1016/j.ypmed.2012.02.002.
  • Shanahan EA, DeLeo RA, Albright EA, Li M, Koebele EA, Taylor K, Crow DA, Dickinson KL, Minkowitz H, Birkland TA, et al. Visual policy narrative messaging improves COVID-19 vaccine uptake. PNAS Nexus. 2023 Apr 1;2(4):pgad080. doi:10.1093/pnasnexus/pgad080.
  • Burgess RA, Osborne RH, Yongabi KA, Greenhalgh T, Gurdasani D, Kang G, Falade AG, Odone A, Busse R, Martin-Moreno JM, et al. The COVID-19 vaccines rush: participatory community engagement matters more than ever. Lancet. 2021;397(10268):8–10. doi:10.1016/S0140-6736(20)32642-8.
  • Hopkins KL, Underwood T, Iddrisu I, Woldemeskel H, Bon HB, Brouwers S, De Almeida S, Fol N, Malhotra A, Prasad S, et al. Community-Based approaches to increase COVID-19 vaccine uptake and demand: lessons learned from four UNICEF-supported interventions. Vaccines (Basel). 2023;11(7):1180. doi:10.3390/vaccines11071180.
  • Lin Y, Hu Z, Zhao Q, Alias H, Danaee M, Wong LP, Marques ETA. Understanding COVID-19 vaccine demand and hesitancy: a nationwide online survey in China. PLoS Negl Trop Dis. 2020;14(12):e0008961. doi:10.1371/journal.pntd.0008961.
  • Kabir R, Mahmud I, Chowdhury MT, Vinnakota D, Jahan SS, Siddika N, Isha SN, Nath SK, Hoque Apu E. COVID-19 vaccination intent and willingness to pay in Bangladesh: a cross-sectional study. Vaccines. 2021;9(5):416. doi:10.3390/vaccines9050416.
  • Banik R, Islam MS, Pranta MU, Rahman QM, Rahman M, Pardhan S, Driscoll R, Hossain S, Sikder MT. Understanding the determinants of COVID-19 vaccination intention and willingness to pay: findings from a population-based survey in Bangladesh. BMC Infect Dis. 2021;21(1):892. doi:10.1186/s12879-021-06406-y.
  • Adigwe OP. COVID-19 vaccine hesitancy and willingness to pay: emergent factors from a cross-sectional study in Nigeria. Vaccine. 2021;9:100112. doi:10.1016/j.jvacx.2021.100112.
  • Vo NX, Nguyen TT, Van Nguyen P, Tran QV, Vo TQ. Using contingent valuation method to estimate adults’ willingness to pay for a future coronavirus 2019 vaccination. Value Health Reg Issues. 2021;24:240–6. doi:10.1016/j.vhri.2021.01.002.
  • Nguyen LH, Hoang MT, Nguyen LD, Ninh LT, Nguyen HT, Nguyen AD, Vu LG, Vu GT, Doan LP, Latkin CA, et al. Acceptance and willingness to pay for COVID‐19 vaccines among pregnant women in Vietnam. Trop Med Int Health. 2021;26(10):1303–13. doi:10.1111/tmi.13666.
  • Das U, Rathore U, Pal R. On willingness to pay for covid-19 vaccines: a case study from India. Hum Vac Immunother. 2021;17(12):4904–13. doi:10.1080/21645515.2021.1989918.
  • Harapan H, Wagner AL, Yufika A, Winardi W, Anwar S, Gan AK, Setiawan AM, Rajamoorthy Y, Sofyan H, Vo TQ, et al. Willingness-to-pay for a COVID-19 vaccine and its associated determinants in Indonesia. Hum Vac Immunother. 2020;16(12):3074–80. doi:10.1080/21645515.2020.1819741.
  • Alhassan RK, Nketiah-Amponsah E, Immurana M, Abuosi AA. Financing COVID-19 vaccination in sub-saharan Africa: lessons from a nation-wide willingness to pay (WTP) survey in Ghana. BMC Pub Health. 2022;22(1):1273. doi:10.1186/s12889-022-13602-1.
  • Shitu K, Wolde M, Handebo S, Kassie A. Acceptance and willingness to pay for COVID-19 vaccine among school teachers in Gondar city, Northwest Ethiopia. Trop Med Health. 2021;49:1–2. doi:10.1186/s41182-021-00337-9.
  • Arshad MS, Hussain I, Mahmood T, Hayat K, Majeed A, Imran I, Saeed H, Iqbal MO, Uzair M, Rehman AU, et al. A national survey to assess the COVID-19 vaccine-related conspiracy beliefs, acceptability, preference, and willingness to pay among the general population of Pakistan. Vaccines. 2021;9(7):720. doi:10.3390/vaccines9070720.
  • Carpio CE, Sarasty O, Hudson D, Macharia A, Shibia M. The demand for a COVID-19 vaccine in Kenya. Hum Vac Immunother. 2021;17(10):3463–71. doi:10.1080/21645515.2021.1938494.
  • Catma S, Reindl D. Parents' willingness to pay for a COVID-19 vaccine for themselves and their children in the United States. Hum Vac Immunother. 2021;17(9):2919–25. doi:10.1080/21645515.2021.1919453.
  • Tung TH, Lin XQ, Chen Y, Wu H, Zhang MX, Zhu JS. Why do parents willingness-to-pay to vaccinate their children against COVID-19? A real-world evidence in Taizhou, China. Hum Vac Immunother. 2022;18(1):1–9. doi:10.1080/21645515.2021.2014731.
  • Wong LP, Alias H, Wong PF, Lee HY, AbuBakar S. The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay. Hum Vac Immunother. 2020;16(9):2204–14. doi:10.1080/21645515.2020.1790279.
  • Forni G, Mantovani A. COVID-19 vaccines: where we stand and challenges ahead. Cell Death Differ. 2021;28(2):626–39. doi:10.1038/s41418-020-00720-9.
  • Rosiello DF, Anwar S, Yufika A, Adam RY, Ismaeil MI, Ismail AY, Dahman NB, Hafsi M, Ferjani M, Sami FS, et al. Acceptance of COVID-19 vaccination at different hypothetical efficacy and safety levels in ten countries in Asia, Africa, and South America. Narra J. 2021;1(3). doi: 10.52225/narra.v1i3.55.
  • Chen L, Xu F, Han Z, Tang K, Hui P, Evans J, Li Y. Strategic COVID-19 vaccine distribution can simultaneously elevate social utility and equity. Nat Hum Behav. 2022;6(11):1503–14. doi:10.1038/s41562-022-01429-0.
  • Yasmin F, Najeeb H, Naeem U, Moeed A, Atif AR, Asghar MS, Nimri N, Saleem M, Bandyopadhyay D, Krittanawong C, et al. Adverse events following COVID‐19 mRNA vaccines: a systematic review of cardiovascular complication, thrombosis, and thrombocytopenia. Immun Inflamm Dis. 2023 Mar;11(3):e807. doi:10.1002/iid3.807.
  • Acevedo-Whitehouse K, Bruno R. Potential health risks of mRNA-based vaccine therapy: a hypothesis. Med Hypotheses. 2023;171:111015. doi:10.1016/j.mehy.2023.111015.
  • World Health Organization. Statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19 pandemic. [accessed 2023 Oct 5]. https://www.who.int/news/item/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic.
  • Abdelmoneim SA, Sallam M, Hafez DM, Elrewany E, Mousli HM, Hammad EM, Elkhadry SW, Adam MF, Ghobashy AA, Naguib M, et al. COVID-19 vaccine booster dose acceptance: systematic review and meta-analysis. Trop Med Infect Dis. 2022;7(10):298. doi:10.3390/tropicalmed7100298.
  • Jacobs ET, Cordova-Marks FM, Farland LV, Ernst KC, Andrews JG, Vu S, Heslin KM, Catalfamo C, Chen Z, Pogreba-Brown K. Understanding low COVID-19 booster uptake among US adults. Vaccine. 2023;41(42):6221–6. doi:10.1016/j.vaccine.2023.08.080.
  • Harapan H, Sallam M, Fathima R, Kusuma HI, Anwar S, Nalapraya WY, Wibowo A, Kumara Wati KD, Medina A, Defrita AH, et al. Willingness to pay (WTP) for COVID-19 vaccine booster dose and its determinants in Indonesia. Infect Dis Report. 2022;14(6):1017–32. doi:10.3390/idr14060101.
  • Palanca-Tan R. Willingness to pay for an annual vaccine in an endemic COVID-19 scenario: a contingent valuation study in Metro Manila, Philippines. Swiss J Econ Stat. 2023;159(1):12. doi:10.1186/s41937-023-00116-9.
  • Pan SJ, Yang YP, Zhang MX, Tung TH. Willingness to pay for booster dose of COVID-19 vaccine among healthcare workers in Taizhou, China. Hum Vac Immunother. 2022;18(5):2063629. doi:10.1080/21645515.2022.2063629.
  • Tran BX, Do AL, Boyer L, Auquier P, Le HT, Le Vu MN, Dang TH, Cao KM, Le LD, Cu LT, et al. Preference and willingness to pay for the regular COVID-19 booster shot in the Vietnamese population: theory-driven discrete choice experiment. JMIR Public Health Surveill. 2023;9(1):e43055. doi:10.2196/43055.
  • Rosen B, Waitzberg R, Israeli A. Israel’s rapid rollout of vaccinations for COVID-19. Isr J Health Policy Res. 2021;10(1):6. doi:10.1186/s13584-021-00440-6.
  • Daems R, Maes E. The race for COVID-19 vaccines: accelerating innovation, fair allocation and distribution. Vaccines. 2022;10(9):1450. doi:10.3390/vaccines10091450.
  • Md Khairi LNH, Fahrni ML, Lazzarino AI. The race for global equitable access to COVID-19 vaccines. Vaccines. 2022;10(8):1306. doi:10.3390/vaccines10081306.
  • Centers for Disease Control and Prevention. Free updated COVID-19 vaccines available to adults. [accessed 2023 Dec 21]. https://www.cdc.gov/vaccines/programs/bridge/index.html.
  • Betti MI, Abouleish AH, Spofford V, Peddigrew C, Diener A, Heffernan JM. COVID-19 vaccination and healthcare demand. Bull Math Biol. 2023;85(5):32. doi:10.1007/s11538-023-01130-x.